GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Niva Bupa Health Insurance Company NIVABUPA.NS · INR

Financials · NSE · 🇮🇳 India

Compare

75.66

-0.55%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue, before interest expense

₹66.95bn

FY2022FY2026

Net income

₹1.31bn

FY2022FY2026

Total assets

₹112.76bn

FY2022FY2026

Shareholders' equity

₹31.99bn

FY2022FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Revenue, before interest expense₹66.95bn₹56.91bn₹44.27bn₹27.99bn₹18.41bn
Operating income₹1.27bn₹4.21bn———
Net income₹1.31bn₹2.14bn₹818.5m₹125.4m−₹1.97bn
Diluted earnings per share0.701.150.430.07-1.06

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Total assets₹112.76bn₹97.60bn₹61.92bn₹38.77bn₹27.19bn
Cash and short-term investments₹1.59bn₹13.08bn———
Total liabilities₹80.77bn₹58.34bn₹22.77bn₹10.21bn₹1.60bn
Debt₹2.50bn₹2.50bn₹2.50bn₹2.50bn₹2.50bn
Shareholders' equity₹31.99bn₹44.94bn₹39.15bn₹28.55bn₹25.58bn
Shares outstanding1,862m1,865m1,891m1,862m1,862m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue, before interest expense₹24.72bn₹21.39bn₹16.11bn₹13.12bn₹13.71bn₹19.87bn₹12.58bn₹12.81bn
Operating income₹1.84bn₹3.41bn−₹876.4m−₹353.1m−₹914.4m₹2.06bn₹132.4m₹582.0m
Net income₹1.38bn₹3.45bn−₹876.4m−₹352.7m−₹914.4m₹2.06bn₹132.4m₹130.2m
Diluted earnings per share0.741.85-0.47-0.19-0.491.110.070.07
Total assets—₹112.76bn—₹106.50bn—₹97.60bn—₹80.89bn
Cash and short-term investments—₹1.59bn—₹883.0m—₹13.08bn——
Debt—₹2.50bn———₹2.50bn—₹2.50bn
Shareholders' equity—₹31.99bn—₹38.08bn—₹44.94bn—₹30.02bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue34.1%——
Net income118.5%——

Valuation history

At each fiscal year end

FY2026FY2025FY2024
Price to earnings110.865.9194.4
Price to sales2.22.53.7

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.